1. Home
  2. SLNO vs SHO Comparison

SLNO vs SHO Comparison

Compare SLNO & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • SHO
  • Stock Information
  • Founded
  • SLNO 1999
  • SHO 1995
  • Country
  • SLNO United States
  • SHO United States
  • Employees
  • SLNO N/A
  • SHO N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SHO Hotels/Resorts
  • Sector
  • SLNO Health Care
  • SHO Consumer Discretionary
  • Exchange
  • SLNO Nasdaq
  • SHO Nasdaq
  • Market Cap
  • SLNO 1.9B
  • SHO 2.1B
  • IPO Year
  • SLNO 2014
  • SHO 1995
  • Fundamental
  • Price
  • SLNO $54.63
  • SHO $10.18
  • Analyst Decision
  • SLNO Strong Buy
  • SHO Hold
  • Analyst Count
  • SLNO 7
  • SHO 6
  • Target Price
  • SLNO $69.86
  • SHO $11.42
  • AVG Volume (30 Days)
  • SLNO 504.7K
  • SHO 2.3M
  • Earning Date
  • SLNO 11-06-2024
  • SHO 11-12-2024
  • Dividend Yield
  • SLNO N/A
  • SHO 3.53%
  • EPS Growth
  • SLNO N/A
  • SHO 89.56
  • EPS
  • SLNO N/A
  • SHO 0.76
  • Revenue
  • SLNO N/A
  • SHO $910,264,000.00
  • Revenue This Year
  • SLNO N/A
  • SHO N/A
  • Revenue Next Year
  • SLNO N/A
  • SHO $6.51
  • P/E Ratio
  • SLNO N/A
  • SHO $13.45
  • Revenue Growth
  • SLNO N/A
  • SHO N/A
  • 52 Week Low
  • SLNO $26.38
  • SHO $9.39
  • 52 Week High
  • SLNO $59.75
  • SHO $11.59
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 51.30
  • SHO 46.06
  • Support Level
  • SLNO $50.69
  • SHO $9.88
  • Resistance Level
  • SLNO $59.75
  • SHO $11.02
  • Average True Range (ATR)
  • SLNO 2.47
  • SHO 0.27
  • MACD
  • SLNO -0.48
  • SHO -0.05
  • Stochastic Oscillator
  • SLNO 43.47
  • SHO 24.18

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. Sunstone's sole source of income is hotel revenue from its hotel ownership segment.

Share on Social Networks: